42 Participants Needed

Effects of Osteopathic Manipulative Therapy on Arrhythmias

TJ
AM
Overseen ByAlyssa M Auerbach
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: New York Institute of Technology
Must be taking: Anticoagulants
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial is testing a hands-on treatment called Osteopathic Manipulative Medicine (OMM) on patients with irregular heartbeats. The goal is to see if this treatment can reduce the number of irregular heartbeats by improving overall body function. Patients will receive either the OMM treatment or another type of evaluation to compare the results.

Research Team

TC

Todd Cohen, MD

Principal Investigator

New York Institute of Technology College of Osteopathic Medicine

Eligibility Criteria

Inclusion Criteria

Subject has an implanted device connected to CareLink, Merlin, or respective web-based monitoring device, for at least one month
Subject has documented diagnosis of a controlled arrhythmia
If subject has been prescribed anticoagulants, the patients has been taking them for at least one month prior to intervention

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive either Osteopathic Manipulative Treatment or Light Touch Treatment for 25 minutes

1 session
1 visit (in-person)

Follow-up

Participants are monitored for changes in cardiac events using the CareLink system

4 weeks
Remote monitoring

Treatment Details

Interventions

  • Light Touch Therapy
  • Osteopathic Manipulative Treatment
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Osteopathic Manipulative TreatmentExperimental Treatment1 Intervention
Group A will receive osteopathic treatment by NMM/OMM board certified attending physicians. The protocol for the OMT intervention group is based on the guidelines set forth previously in textbooks. The protocol will last 25 minutes total, with 10 minutes for the evaluation and 15 minutes for treatment. The protocol will start in ribs so as to not exacerbate any tachyarrhythmias with rib raising, thoracic myofascial release, and a pectoralis lift. The investigator will then proceed with opening the thoracic inlet, cervical myofascial release, suboccipital release, and then end by checking for and treating Chapman's points. The physician will submit their osteopathic evaluation and fill out a form in order to determine if certain arrhythmias have an associated trigger point.
Group II: Light Touch TreatmentPlacebo Group1 Intervention
Group B will receive a light touch treatment, based on previous research done studying heart rate variability and OMM, where sham treatment was utilized. The protocol consisted of contacting the right ankle, left knee, right hip, diaphragm, right shoulder, neck, and cranium for precisely two minutes each, with the goal of preventing placebo autonomic nervous system stimulation. The protocol is 25 minutes long, with 10 minutes for the evaluation and 15 minutes for treatment.

Osteopathic Manipulative Treatment is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as OMT for:
  • Positional plagiocephaly
  • Deformational plagiocephaly
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as OMT for:
  • Positional plagiocephaly
  • Deformational plagiocephaly

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York Institute of Technology

Lead Sponsor

Trials
56
Recruited
2,300+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity